Oral Vaccination with Engineered Probiotic <i>Limosilactobacillus reuteri</i> Has Protective Effects against Localized and Systemic <i>Staphylococcus aureus</i> Infection.

Microbiol Spectr · 2023 · PMC10100842 · PMID 36723073

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differences with P values of <0.05 or <0.01 were considered significant or highly significant, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Oral Vaccination with Engineered Probiotic &lt;i&gt;Limosilactobacillus reuteri&lt;/i&gt; Has Protective Effects against Localized and Systemic &lt;i&gt;Staphylococcus aureus&lt;/i&gt; Infection.

The sentences

Oral Vaccination with Engineered Probiotic <i>Limosilactobacillus reuteri</i> Has Protective Effects against Localized and Systemic <i>Staphylococcus aureus</i> Infection.